Lexpos News

/Lexpos News/

MHRA Class 4 Medicines Defect Information: Concerta® XL 18mg & 36 mg prolonged release tablets (Orifarm UK Ltd)

Class 4 Medicines Defect Information: Concerta® XL 18mg & 36 mg prolonged release tablets (Orifarm UK Ltd) Drug alert number: EL (24)A/07 Date issued: 26 February 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Concerta® XL 18mg & 36 mg prolonged release tablets (Orifarm [...]

The post MHRA Class 4 Medicines Defect Information: Concerta® XL 18mg & 36 mg prolonged release tablets (Orifarm UK Ltd) appeared first on Community Pharmacy England.

By |February 26th, 2024|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Information: Concerta® XL 18mg & 36 mg prolonged release tablets (Orifarm UK Ltd)

National Patient Safety Alert DHSC: Shortage of salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials

National Patient Safety Alert: Shortage of salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials National Patient Safety Alert Reference Number: NatPSA/2024/003/DHSC_MVA Date issued: 26 February 2024 Explanation of identified safety issue A Medicines Supply Notification (MSN) issued on 14 February 2024, detailed a shortage of salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid. The resolution date [...]

The post National Patient Safety Alert DHSC: Shortage of salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials appeared first on Community Pharmacy England.

By |February 26th, 2024|Lexpos News|Comments Off on National Patient Safety Alert DHSC: Shortage of salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials

Negotiations on 2024/25 Contractual Framework Commence

Formal tripartite negotiations on the arrangements for the Community Pharmacy Contractual Framework (CPCF) in 2024/25 – the first year following the five-year CPCF deal – have now begun. The negotiations are taking place between Community Pharmacy England and the Department of Health and Social Care (DHSC), supported by NHS England (NHSE). They are beginning ahead [...]

The post Negotiations on 2024/25 Contractual Framework Commence appeared first on Community Pharmacy England.

By |February 23rd, 2024|Lexpos News|Comments Off on Negotiations on 2024/25 Contractual Framework Commence

Codeine Linctus reclassification from P to POM

This week the MHRA announced that codeine linctus would be reclassified to a prescription-only medicine because of the risk of abuse and addiction that comes with it being available over-the-counter. Please see more information here: Codeine linctus to be reclassified to a prescription-only medicine because of risk of abuse and addiction – GOV.UK (www.gov.uk) We [...]

The post Codeine Linctus reclassification from P to POM appeared first on Community Pharmacy England.

By |February 23rd, 2024|Lexpos News|Comments Off on Codeine Linctus reclassification from P to POM

February 2024 Price Concessions 3rd Update

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (23/02/2024) announced the following list of price concessions for February 2024. Please note: We are still in discussion with DHSC on a number other medicines affected by pricing [...]

The post February 2024 Price Concessions 3rd Update appeared first on Community Pharmacy England.

By |February 23rd, 2024|Lexpos News|Comments Off on February 2024 Price Concessions 3rd Update